Angiodynamics, Inc. operates in the Surgical and medical instruments sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Angiodynamics with three other
companies in this sector in UNITED STATES :
sales of $276.22 million
of which 71%
was Medical Devices),
Cardiovascular Systems, Incorporation
of which 72%
was Peripheral Products), and
Mimedx Group, Incorporation
of which 100%
was emerging therapeutic biologics company).
Angiodynamics reported sales of $270.63 million
May of 2019.
decrease of 21.4%
versus 2018, when the company's sales were $344.29 million.